Collagenase-type matrix metalloprotease (MMP) activity inhibitor and oral composition
JP2024175353APending Publication Date: 2024-12-18SUNSTAR INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- JP2023093067
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-06-06
- Publication Date
- 2024-12-18
Abstract
To provide a collagenase-type matrix metalloprotease (MMP) activity inhibitor that exhibits superior collagenase-type matrix metalloprotease (MMP) activity inhibitory action, and an oral composition.SOLUTION: A collagenase-type matrix metalloprotease (MMP) activity inhibitor contains 0.35 mass% or more of citric acid. The collagenase-type matrix metalloprotease (MMP) activity inhibitor according to the present invention also contains 0.05 mass% or more of citric acid and 0.025 mass% or more of β-glycyrrhetinic acid. A liquid oral composition according to the present invention contains 0.35 mass% or more of citric acid. The oral composition according to the present invention also contains 0.05 mass% or more of citric acid and 0.025 mass% or more of β-glycyrrhetinic acid.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art